Oncotech launches the first-ever mobile cancer screening tool

Oncotech's real-time cancer diagnostic tool lets you check for cancer right from your smartphone

Doctor touching a screen with reflections of medial things

Oncotech‌ ‌Nordic‌ ‌AB has developed a mobile cancer diagnosis tool that can spot precancerous symptoms and underlying cancer-related diseases.

Dubbed Ophtascan, the real-time screening and detection system can also identify all four stages of cancer and targeted oncological diseases in the human body.

"By simply using their own smartphone devices, users can photograph their iris, and upload the image to Oncotech's server," said Oncotech.

Oncotech's artificial intelligence-powered diagnostic and deep learning system then sends the results back to the user. All of this happens in under 25 seconds.

"People will be able to self-diagnose for pre-cancerous and targeted existing cancerous conditions via a smartphone in-real time. The process is quick, on demand, cost effective - and does not overload the public health care diagnostic system unnecessarily, hence eliminating patient cancer screening waiting lists," explained Andre Rafnsson, Oncotech CEO.

Ophtascan can screen for lung cancer, liver cancer, breast cancer, uterine cancer, and prostate cancer in its current version.

Ophtascan was validated last year following tests on 800 oncology patients over three years. The tool's scanning precision hit a reported 96% success rate. Rafnsson anticipates reaching a 98-99% precision scanning rate by the third quarter of 2021.

Related Resource

IT Pro 20/20: Understanding our complicated relationship with AI

The 16th issue of IT Pro 20/20 looks at the very human problems associated with artificial intelligence

IT Pro 20/20: Understanding our complicated relationship with AIDOWNLOAD NOW

Furthermore, a new study is underway to determine whether Ophtascan tests can provide early warning signs for Type 2 diabetes.

"Our patent is now pending for the software and design algorithms. We have diligently started discussions with several telemedicine and remote health diagnostic business partners in Europe, North America and Asia with a view to license the Ophtascan™ technology," added Rafnsson.

"Technically advanced businesses can see the potential impact of this breakthrough in increased positive medical outcomes for patients. Many factors determine cancer survival rate, and early detection is one of the most significant determinants. Ophtascan ™ is precise, quick, well documented and is highly cost-effective."

Featured Resources

Defeating ransomware with unified security from WatchGuard

How SMBs can defend against the onslaught of ransomware attacks

Free download

The IT expert’s guide to AI and content management

How artificial intelligence and machine learning could be critical to your business

Free download

The path to CX excellence

Four stages to thrive in the experience economy

Free download

Becoming an experience-based business

Your blueprint for a strong digital foundation

Free download

Recommended

Sensome’s AI-powered stroke guidewire begins human trials in Australia
artificial intelligence (AI)

Sensome’s AI-powered stroke guidewire begins human trials in Australia

13 Sep 2021
Medigate and CrowdStrike bolster IoT medical device security
Internet of Things (IoT)

Medigate and CrowdStrike bolster IoT medical device security

10 Sep 2021
Commerce Department creates an artificial intelligence committee
Policy & legislation

Commerce Department creates an artificial intelligence committee

9 Sep 2021
Yext’s Find-a-Doc streamlines finding a doctor with AI
artificial intelligence (AI)

Yext’s Find-a-Doc streamlines finding a doctor with AI

8 Sep 2021

Most Popular

Zoom: From pandemic upstart to hybrid work giant
video conferencing

Zoom: From pandemic upstart to hybrid work giant

14 Sep 2021
What are the pros and cons of AI?
machine learning

What are the pros and cons of AI?

8 Sep 2021
Google takes down map showing homes of 111,000 Guntrader customers
data breaches

Google takes down map showing homes of 111,000 Guntrader customers

2 Sep 2021